Esophageal Tumor Cells

Yes, our collection includes cell lines derived not only from primary esophageal tumors but also from metastatic sites such as lymph nodes, pleural effusions, and ascites. Comparing the behavior and molecular profiles of matched primary and metastatic cell lines can provide valuable insights into the mechanisms of invasion and metastasis. For example, models established from metastatic lesions may exhibit enhanced migratory and invasive properties in in vitro assays.

Most human esophageal tumor cell lines adhere well and are cultured in standard humidified incubators at 37°C with 5% CO₂. They are typically maintained in RPMI 1640 or DMEM medium, supplemented with 10% fetal bovine serum (FBS). However, specific nutritional requirements or recommended doubling times can vary between lines. Detailed, cell line-specific culture protocols are provided with each product to ensure optimal growth and experimental consistency.

Absolutely. Esophageal tumor cell lines are foundational for building more physiologically relevant models. They are commonly used in co-culture systems with cancer-associated fibroblasts (CAFs), immune cells, or endothelial cells to study cell-cell interactions within the TME. Additionally, they are suitable for establishing 3D spheroids or organoids, which better mimic the tumor architecture and can be used to investigate drug penetration, hypoxia, and stromal effects.

We offer select pairs of esophageal tumor cell lines where one is the parental line and the other is a derived subline with characterized resistance to common chemotherapeutics like cisplatin or 5-fluorouracil. These isogenic pairs are powerful tools for comparative studies aimed at unraveling the molecular mechanisms underlying acquired drug resistance, a major hurdle in esophageal cancer treatment.

Many of our esophageal tumor cell lines have been validated for their ability to form tumors in immunodeficient mice ( e.g. , nude or NSG mice), making them excellent models for establishing cell-derived xenografts (CDX). Tumor growth rates, take rates, and histopathology can vary between lines. We recommend consulting the product information or our technical support team for guidance on selecting the most appropriate model for your specific in vivo research objectives.

Our dedicated scientific support team is available to assist with experimental design, protocol optimization, and troubleshooting. We can provide guidance on cell line selection based on your research goals, share published application notes, and discuss best practices for assays commonly performed with these models, such as proliferation, migration, invasion, and drug sensitivity testing.